281652-58-2Relevant articles and documents
An anti-diabetic drug intermediate and preparation method thereof
-
Paragraph 0023-0028, (2022/01/12)
The present invention discloses an antidiabetic drug intermediate and a method for preparing it, comprising: the 2-chloro-5-iodobenzoic acid first reacted with a halogenated reagent, the reaction was complete and then added 2-fluorophene and Lewis acid fo
GLUCOPYRANOSE DERIVATIVES USEFUL AS SGLT2 INHIBITORS
-
Page/Page column 61, (2020/06/10)
The present invention is directed to glucopyranose derivatives of formula (I), pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by SGLT2 activity. More particularly, the compounds of the present invention are useful in the treatment of for example, Type II diabetes mellitus, Syndrome X, and complications and symptoms associated with said disorders.
Preparation method of empagliflozin intermediate impurity
-
Paragraph 0030; 0033; 0040; 0044-0045, (2020/07/24)
The invention relates to the field of drug synthesis, in particular to a preparation method of an empagliflozin intermediate impurity (S)-3-(2-(2-chloro-5-iodobenzyl) phenoxy)tetrahydrofuran. The invention discloses a preparation method of an empagliflozi